Literature DB >> 27890381

Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei.

Tanja Schirmeister1, Janina Schmitz2, Sascha Jung3, Torsten Schmenger4, R Luise Krauth-Siegel4, Michael Gütschow2.   

Abstract

A series of dipeptide nitriles known as inhibitors of mammalian cathepsins were evaluated for inhibition of rhodesain, the cathepsin L-like protease of Trypanosoma brucei. Compound 35 consisting of a Leu residue fitting into the S2 pocket and a triarylic moiety consisting of thiophene, a 1,2,4-oxadiazole and a phenyl ring fitting into the S3 pocket, and compound 33 with a 3-bromo-Phe residue (S2) and a biphenyl fragment (S3) were found to inhibit rhodesain in the single-digit nanomolar range. The observed steep structure-activity relationship could be explained by covalent docking simulations. With their high selectivity indices (ca. 200) and the good antitrypanosomal activity (8μM) the compounds represent promising starting points for new rhodesain inhibitors. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cysteine protease; Dipeptide nitrile; Inhibitor; Rhodesain; Trypanosoma

Mesh:

Substances:

Year:  2016        PMID: 27890381     DOI: 10.1016/j.bmcl.2016.11.036

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain.

Authors:  Santo Previti; Roberta Ettari; Elsa Calcaterra; Carla Di Chio; Rahul Ravichandran; Collin Zimmer; Stefan Hammerschmidt; Annika Wagner; Marta Bogacz; Sandro Cosconati; Tanja Schirmeister; Maria Zappalà
Journal:  ACS Med Chem Lett       Date:  2022-06-30       Impact factor: 4.632

2.  Naphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases-Studies on Inhibition Mechanism and Kinetics.

Authors:  Philipp Klein; Fabian Barthels; Patrick Johe; Annika Wagner; Stefan Tenzer; Ute Distler; Thien Anh Le; Paul Schmid; Volker Engel; Bernd Engels; Ute A Hellmich; Till Opatz; Tanja Schirmeister
Journal:  Molecules       Date:  2020-04-28       Impact factor: 4.411

Review 3.  Cysteine proteases in protozoan parasites.

Authors:  Jair L Siqueira-Neto; Anjan Debnath; Laura-Isobel McCall; Jean A Bernatchez; Momar Ndao; Sharon L Reed; Philip J Rosenthal
Journal:  PLoS Negl Trop Dis       Date:  2018-08-23

Review 4.  Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases.

Authors:  Simone Brogi; Roberta Ibba; Sara Rossi; Stefania Butini; Vincenzo Calderone; Sandra Gemma; Giuseppe Campiani
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

5.  Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.

Authors:  Santo Previti; Roberta Ettari; Carla Di Chio; Rahul Ravichandran; Marta Bogacz; Ute A Hellmich; Tanja Schirmeister; Sandro Cosconati; Maria Zappalà
Journal:  Molecules       Date:  2022-06-11       Impact factor: 4.927

6.  The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation.

Authors:  Radwa E Mahgoub; Feda E Mohamed; Lara Alzyoud; Bassam R Ali; Juliana Ferreira; Wael M Rabeh; Shaikha S AlNeyadi; Noor Atatreh; Mohammad A Ghattas
Journal:  Molecules       Date:  2022-10-09       Impact factor: 4.927

7.  New Cysteine Protease Inhibitors: Electrophilic (Het)arenes and Unexpected Prodrug Identification for the Trypanosoma Protease Rhodesain.

Authors:  Philipp Klein; Patrick Johe; Annika Wagner; Sascha Jung; Jonas Kühlborn; Fabian Barthels; Stefan Tenzer; Ute Distler; Waldemar Waigel; Bernd Engels; Ute A Hellmich; Till Opatz; Tanja Schirmeister
Journal:  Molecules       Date:  2020-03-23       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.